Cargando…

Increased Collagen Type V α2 (COL5A2) in Colorectal Cancer is Associated with Poor Prognosis and Tumor Progression

PURPOSE: Colorectal cancer (CRC) is the third most common cancer in males and the second in females worldwide with very poor prognosis. Extracellular matrix proteins like collagens play important roles in cancer progression. Collagen type V α2 (COL5A2) is increased in several cancers but its role in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jie, Jiang, Ying-Hua, Yang, Peng-Yuan, Liu, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107053/ https://www.ncbi.nlm.nih.gov/pubmed/33981148 http://dx.doi.org/10.2147/OTT.S288422

Ejemplares similares

High expression of COL10A1 is associated with poor prognosis in colorectal cancer
por: Huang, Haipeng, et al.
Publicado: (2018)

Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer
por: Huang, Xiaodong, et al.
Publicado: (2020)

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
por: Gu, Sujie, et al.
Publicado: (2021)

High Expression of COL17A1 Predicts Poor Prognosis and Promotes the Tumor Progression via NF-κB Pathway in Pancreatic Adenocarcinoma
por: Mao, Feiyu, et al.
Publicado: (2020)

High expression COL10A1 promotes breast cancer progression and predicts poor prognosis
por: Zhou, Weijian, et al.
Publicado: (2022)

Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma
por: Hu, Liang, et al.
Publicado: (2015)

Increased ATP2A1 Predicts Poor Prognosis in Patients With Colorectal Carcinoma
por: Zhang, Guoshun, et al.
Publicado: (2022)

COL3A1 Overexpression Associates with Poor Prognosis and Cisplatin Resistance in Lung Cancer
por: Wang, Lihuai, et al.
Publicado: (2022)

AP-2α expression in papillary thyroid carcinoma predicts tumor progression and poor prognosis
por: Wu, Hong Rong, et al.
Publicado: (2018)

Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics
por: Qiao, Jie, et al.
Publicado: (2015)

CRISPR-activated expression of collagen col-120 increases lifespan and heat tolerance
por: Goyala, Anita, et al.
Publicado: (2023)

UBN2 promotes tumor progression via the Ras/MAPK pathway and predicts poor prognosis in colorectal cancer
por: Zhao, Ya-li, et al.
Publicado: (2019)

Cryptochrome 1 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer
por: Yu, Hongyan, et al.
Publicado: (2013)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study
por: Huang, Feng, et al.
Publicado: (2020)

Grainyhead-like 2 Promotes Tumor Growth and is Associated with Poor Prognosis in Colorectal Cancer
por: Quan, Yingjun, et al.
Publicado: (2015)

Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer
por: Lin, Xiao-Lu, et al.
Publicado: (2017)

GABRD promotes progression and predicts poor prognosis in colorectal cancer
por: Niu, Gengming, et al.
Publicado: (2020)

Cyclooxygenase-2 expression in the tumor environment is associated with poor prognosis in colorectal cancer patients
por: LIN, PENG-CHAN, et al.
Publicado: (2013)

Association of tricellulin expression with poor colorectal cancer prognosis and metastasis
por: Zhang, Jin-Xiu, et al.
Publicado: (2020)

Post-Adipose-Derived Stem Cells (ADSC) Stimulated by Collagen Type V (Col V) Mitigate the Progression of Osteoarthritic Rabbit Articular Cartilage
por: Brindo da Cruz, Isabele Camargo, et al.
Publicado: (2021)

COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer
por: Owusu-Ansah, Kwabena Gyabaah, et al.
Publicado: (2019)

Radiation increases COL1A1, COL3A1, and COL1A2 expression in breast cancer
por: Yao, Guorong, et al.
Publicado: (2022)

Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma
por: Hu, Liang, et al.
Publicado: (2016)

CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis
por: Wang, Ji-Lin, et al.
Publicado: (2016)

Differential expression of COL4A3 and collagen in upward and downward progressing types of nasopharyngeal carcinoma
por: Yang, Xiting, et al.
Publicado: (2021)

Structural changes in mixed Col I/Col V collagen gels probed by SHG microscopy: implications for probing stromal alterations in human breast cancer
por: Ajeti, Visar, et al.
Publicado: (2011)

The influence of tag sequence on recombinant humanized collagen (rhCol) and the evaluation of rhCol on Schwann cell behaviors
por: Bai, Mingxuan, et al.
Publicado: (2023)

Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing
por: Maruelli, Silvia, et al.
Publicado: (2020)

Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis
por: Zhang, Lihua, et al.
Publicado: (2020)

ceRNA network-regulated COL1A2 high expression correlates with poor prognosis and immune infiltration in colon adenocarcinoma
por: Yuan, Xia, et al.
Publicado: (2023)

Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis
por: Sun, Jian, et al.
Publicado: (2016)

High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer
por: Zhang, Xuezhou, et al.
Publicado: (2022)

Downregulation of DUSP9 Promotes Tumor Progression and Contributes to Poor Prognosis in Human Colorectal Cancer
por: Qiu, Zhaoyan, et al.
Publicado: (2020)

High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer
por: Li, Siman, et al.
Publicado: (2020)

Role of COL6A3 in colorectal cancer
por: Liu, Wei, et al.
Publicado: (2018)

ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer
por: Gupta, Nikhil, et al.
Publicado: (2019)

Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients
por: Peng, LingLong, et al.
Publicado: (2017)

SUMO-Activating Enzyme Subunit 1 Is Associated with Poor Prognosis, Tumor Progression, and Radio-Resistance in Colorectal Cancer
por: Wu, Yueh-Jung, et al.
Publicado: (2023)

Predictions for high COL1A1 and COL10A1 expression resulting in a poor prognosis in esophageal squamous cell carcinoma by bioinformatics analyses
por: Li, Yang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j7tjda6be2deidveha7cs4ojsq